|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
+2.16% | +2.16% |
| 01-09 | Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2000 Value Benchmark | CI |
| 01-09 | Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2500 Value Benchmark | CI |
| Market Cap | 6.96B 6.08B 5.63B 5.16B 9.77B 671B 9.94B 67.09B 26.35B 327B 26.13B 25.56B 1,131B | P/E 2023 |
-3.03x | P/E 2024 | -1.01x |
|---|---|---|---|---|---|
| Enterprise Value | 6.77B 5.92B 5.47B 5.02B 9.51B 653B 9.67B 65.29B 25.65B 319B 25.43B 24.88B 1,100B | EV / Sales 2023 |
0.64x | EV / Sales 2024 | 84.5x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: Cidara Therapeutics
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Karbe
DFI | Director of Finance/CFO | 58 | 24/02/2025 |
Corrina Pavetto
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/05/2025 |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 63.9M 55.86M 51.66M 47.4M 89.72M 6.16B 91.28M 616M 242M 3.01B 240M 235M 10.38B | 1.28M 1.11M 1.03M 946K 1.79M 123M 1.82M 12.29M 4.83M 60M 4.79M 4.68M 207M |
| Net income | -22.93M -20.04M -18.54M -17.01M -32.19M -2.21B -32.75M -221M -86.84M -1.08B -86.12M -84.22M -3.73B | -170M -148M -137M -126M -238M -16.36B -243M -1.64B -643M -7.99B -638M -624M -27.59B |
| Net Debt | -30.9M -27.01M -24.98M -22.92M -43.38M -2.98B -44.14M -298M -117M -1.45B -116M -113M -5.02B | -186M -163M -151M -138M -261M -17.95B -266M -1.8B -705M -8.76B -699M -684M -30.26B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CDTX Stock
- 20D Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
